Cohen Neil Harris bought CMMB
March 21, 2023 · Form 4 insider transaction
Cohen Neil Harris bought 1,714 shares of Chemomab Therapeutics Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1260 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,714
Price
$0.00
Total value
N/A
InsiderCohen Neil Harris
Role—
SecurityStock option (right to buy American Depositary Shares)
Transaction codeA: Grant or award
Transaction dateMarch 21, 2023
Filing dateSeptember 1, 2026
Shares owned after6,562
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options reported in this row were granted to the Reporting Person by the Issuer on March 21, 2023, and are fully vested and exercisable as of the date of this report.